Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ironwood Pharmaceuticals Inc (IRWD)  
$5.83 0.15 (2.51%) as of 4:30 Fri 6/14


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 173,744,000
Market Cap: 1.01(B)
Last Volume: 148,509 Avg Vol: 0
52 Week Range: $5.88 - $15.45
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 8.3
Insider 3/6 Months : 8.9
Guru Rank Number :  607
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focusing on developing the treatment of GI diseases. LINZESS® (linaclotide), Co.'s commercial product, is a product in a class of GI medicines called guanylate cyclase type C agonists and is indicated for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). LINZESS is available to adult men and women suffering from IBS-C or CIC in the U.S. and Mexico and to adult men and women suffering from IBS-C in Japan and China. Co. has partnerships with pharmaceutical companies to support the development and commercialization of linaclotide.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 17,604 53,676 53,676
Total Buy Value $0 $160,420 $460,539 $460,539
Total People Bought 0 2 2 2
Total Buy Transactions 0 2 3 3
Total Shares Sold 226,641 507,557 529,791 1,205,966
Total Sell Value $1,459,885 $5,741,044 $5,974,538 $13,645,593
Total People Sold 6 7 8 11
Total Sell Transactions 7 12 16 50
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 922
  Page 18 of 37  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Consylman Gina Chief Accounting Officer   •       –      –    2017-02-24 4 S $16.53 $48,962 D/D (2,962) 26,822     -
   Gilbert Halley E Chief Legal Officer   •       –      –    2017-02-22 4 AS $16.94 $85,361 D/D (5,039) 60,807     -
   Consylman Gina Chief Accounting Officer   •       –      –    2017-02-22 4 AS $16.94 $31,153 D/D (1,839) 29,784     -
   Mccourt Thomas A Chief Commercial Officer   •       –      –    2017-02-22 4 AS $16.94 $25,749 D/D (1,520) 28,050     -
   Graney Thomas Chief Financial Officer   •       –      –    2017-02-22 4 AS $16.94 $31,746 D/D (1,874) 20,763     -
   Currie Mark G Chief Scientific Officer   •       –      –    2017-02-22 4 AS $16.94 $30,492 D/D (1,800) 21,258     -
   Gilbert Halley E Chief Legal Officer   •       –      –    2017-02-14 4 AS $16.75 $626,199 D/D (37,385) 0     -
   Gilbert Halley E Chief Legal Officer   •       –      –    2017-02-14 4 OE $3.76 $140,568 D/D 37,385 37,385     -
   Currie Mark G Chief Scientific Officer   •       –      –    2017-01-18 4 OE $2.94 $164,602 D/D 55,987 775,000     -
   Hecht Peter M Chief Executive Officer   •       •      –    2017-01-12 4 AS $15.50 $511,407 D/D (32,994) 4,670,322     -
   Hecht Peter M Chief Executive Officer   •       •      –    2017-01-12 4 OE $2.94 $97,002 D/D 32,994 4,703,316     -
   Hecht Peter M Chief Executive Officer   •       •      –    2017-01-11 4 AS $15.84 $522,609 D/D (32,993) 4,670,322     -
   Hecht Peter M Chief Executive Officer   •       •      –    2017-01-11 4 OE $2.94 $96,999 D/D 32,993 4,703,315     -
   Currie Mark G Chief Scientific Officer   •       –      –    2017-01-06 4 OE $2.94 $99,998 D/D 34,013 719,013     -
   Schulman Amy W Director   –       •      –    2017-01-01 4 A $0.00 $0 D/D 9,793 9,793     -
   Consylman Gina Chief Accounting Officer   •       –      –    2016-12-16 4 A $0.00 $0 D/D 10,500 31,623     -
   Walsh Christopher T Phd Director   –       •      –    2016-12-15 4 A $0.00 $0 D/D 161 71,357     -
   Mcguire Terrance Director   –       •      –    2016-12-15 4 A $0.00 $0 D/D 161 44,414     -
   Currie Mark G Chief Scientific Officer   •       –      –    2016-12-07 4 GD $0.00 $0 D/D 2,500 23,058     -
   Olanoff Lawrence S Director   –       •      –    2016-12-05 4 AS $15.68 $50,176 D/D (3,200) 26,105     -
   Gilbert Halley E Chief Legal Officer   •       –      –    2016-11-11 4 AS $16.75 $234,500 D/D (14,000) 0     -
   Gilbert Halley E Chief Legal Officer   •       –      –    2016-11-11 4 OE $3.76 $52,640 D/D 14,000 14,000     -
   Currie Mark G Chief Scientific Officer   •       –      –    2016-10-31 4 OE $2.94 $882,000 D/D 300,000 685,000     -
   Walsh Christopher T Phd Director   –       •      –    2016-09-15 4 A $0.00 $0 D/D 166 71,196     -
   Mcguire Terrance Director   –       •      –    2016-09-15 4 A $0.00 $0 D/D 166 44,253     -
  922 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 18 of 37
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us